Oxidative lipoprotein markers predict poor functional outcome in patients with minor stroke or transient ischaemic attack

European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
An-Xin WangCHANCE Study Group

Abstract

Oxidative stress plays an important role in acute ischaemic stroke. However, the association of oxidative lipoprotein markers, including oxidized low-density lipoprotein (oxLDL), oxLDL:high-density lipoprotein (HDL) and oxLDL:low-density lipoprotein (LDL), with functional outcome of minor stroke or transient ischaemic attack (TIA) remains unclear. We aimed to investigate the association between oxidative lipoprotein markers and poor functional outcome in patients with minor stroke or TIA. All patients with minor stroke or TIA were recruited from the Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) trial. The poor functional outcome included modified Rankin Scale (mRS) score 2-6 and 3-6 at 90-day and 12-month follow-up. Multivariate logistic regression was used to investigate the associations of oxLDL, oxLDL:HDL and oxLDL:LDL with poor functional outcome. Among 3019 patients included in this study, the median (interquartile range) oxLDL, oxLDL:HDL and oxLDL:LDL were 13.96 (6.65-28.81), 4.52 (2.08-9.32) and 11.73 (5.27-24.85) μg/dL, respectively. After adjusted for confounding factors, patients in the highest oxLDL quartile had a higher proportion of mRS score 2-6 at 90 days [hazard ratio...Continue Reading

References

Jun 1, 1978·European Journal of Clinical Investigation·D Steinberg
Jul 29, 1991·FEBS Letters·M I MacknessP N Durrington
May 1, 1989·Statistics in Medicine·S Durrleman, R Simon
Jan 25, 2002·Annals of the New York Academy of Sciences·A BoullierJ L Witztum
Oct 16, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·Kyoko NishiShinji Nagahiro
Feb 18, 2003·Journal of Neurology, Neurosurgery, and Psychiatry·M UnoS Nagahiro
Apr 22, 2005·The New England Journal of Medicine·Göran K Hansson
Jul 8, 2005·The New England Journal of Medicine·Sotirios TsimikasPeter B Berger
Feb 24, 2006·The American Journal of Cardiology·Nina JohnstonLars Wallentin
Mar 3, 2007·Journal of Atherosclerosis and Thrombosis·Hiroyuki Itabe, Makiko Ueda
Oct 2, 2007·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Josefa GironaLluís Masana
Nov 26, 2009·International Journal of Stroke : Official Journal of the International Stroke Society·C L Allen, U Bayraktutan
Jun 15, 2011·Neurological Research·Ruile FangYongjun Wang
Jun 28, 2013·The New England Journal of Medicine·Yongjun WangUNKNOWN CHANCE Investigators
Aug 13, 2013·Mediators of Inflammation·Angela PirilloAlberico Luigi Catapano
Oct 1, 2013·Clinica Chimica Acta; International Journal of Clinical Chemistry·Nai-Wen TsaiCheng-Hsien Lu
Jun 5, 2014·BioMed Research International·Nai-Wen TsaiCheng-Hsien Lu
Dec 30, 2014·Critical Reviews in Clinical Laboratory Sciences·Andreja TrpkovicEsma R Isenovic
May 9, 2015·Patient Education and Counseling·Krystyna JaraczWojciech Kozubski
Aug 19, 2015·Neurology·Xianwei WangUNKNOWN CHANCE investigators
Dec 3, 2016·Stroke; a Journal of Cerebral Circulation·Anxin WangYilong Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.